Psyence BioMed settles shareholder litigation for $1.5 million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. NVDA
2. CRWV
3. SPY
4. IRON
5. EYPT
6. SLGN
7. STLD
8. CHRD
9. AMZN
10. CLF

Go back to Psyence BioMed settles shareholder litigation for $1.5 million

Psyence BioMed Announces Settlement of Shareholder Litigation

February 11, 2026 9:15 AM EST

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed" or the "Company") today announced that it has entered into a settlement agreement to resolve a direct shareholder claim made by KAOS Capital Ltd ("KAOS"). The claim, originally made on January 14, 2026, and amplified on January 26, 2026, alleged, among other things, improper and oppressive actions on the part of the Company against KAOS, resulting in KAOS suffering alleged damages (the "KAOS Allegations"). The Company, its board of directors ("Board") and officers have... More